Nestlé is facing "legal action" from India's food-safety regulator over accusations of "non-compliance" in the Swiss giant's infant formulas.
Three "adjudication cases" have been lodged by the Food Safety and Standards Authority of India (FSSAI) pertaining to Nestlé's NAN Excella Pro Stage 1 and Lactogen Pro 1 infant powders, along with an alleged shortcoming over biotin.
The FSSAI claims the world's largest food manufacturer is in violation of the FSS Act regarding "several non-compliances".
Nestlé's business unit in India insists it is in "adherence" with all FSSAI regulations as the safety body said it had an issue with "promotional material available on e-commerce platforms" relating to the formulas concerned.
"In NAN Excella Pro Stage 1, claims relating to '5 HMOs' and 'Whey Protein' were observed, while in Lactogen Pro 1, a claim relating to 'Whey Protein' being easy to digest was observed," the FSSAI said in a social media post.
"Accordingly, clarifications were sought from M/s Nestlé India Limited regarding the above claims."
The regulator did not fully explain what the non-compliance contraventions were, nor did it outline the nature of the five human milk ...
